Product
Vaxelis™
2 clinical trials
4 indications
Indication
VaccinesIndication
CombinedIndication
Hexavalent VaccineIndication
Pneumococcal InfectionsClinical trial
A Phase 4, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of Vaxelis™ in Healthy Children Previously Vaccinated With a 2-Dose Primary Infant Series of Either Vaxelis™ or Hexyon™Status: Completed, Estimated PCD: 2022-08-30
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Active-comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2)Status: Completed, Estimated PCD: 2021-10-29